101 related articles for article (PubMed ID: 27959443)
1. An epirubicin-peptide conjugate with anticancer activity is dependent upon the expression level of the surface transferrin receptor.
Yang J; Yang Q; Xu L; Lou J; Dong Z
Mol Med Rep; 2017 Jan; 15(1):323-330. PubMed ID: 27959443
[TBL] [Abstract][Full Text] [Related]
2. Transferrin Receptor Targeted Cellular Delivery of Doxorubicin Via a Reduction-Responsive Peptide-Drug Conjugate.
Li S; Zhao H; Mao X; Fan Y; Liang X; Wang R; Xiao L; Wang J; Liu Q; Zhao G
Pharm Res; 2019 Oct; 36(12):168. PubMed ID: 31654226
[TBL] [Abstract][Full Text] [Related]
3. Tumor cell targeting of transferrin-PEG-TNF-alpha conjugate via a receptor-mediated delivery system: design, synthesis, and biological evaluation.
Jiang YY; Liu C; Hong MH; Zhu SJ; Pei YY
Bioconjug Chem; 2007; 18(1):41-9. PubMed ID: 17226956
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity and toxicity of transferrin receptor-targeted hybrid peptide as a potent anticancer agent.
Kawamoto M; Kohno M; Horibe T; Kawakami K
Cancer Chemother Pharmacol; 2013 Mar; 71(3):799-807. PubMed ID: 23328867
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis, and in vitro antitumor activity of a transferrin receptor-targeted peptide-doxorubicin conjugate.
Li S; Zhao H; Fan Y; Zhao G; Wang R; Wen F; Wang J; Wang X; Wang Y; Gao Y
Chem Biol Drug Des; 2020 Jan; 95(1):58-65. PubMed ID: 31452330
[TBL] [Abstract][Full Text] [Related]
6. In vitro assessment of transferrin-conjugated liposomes as drug delivery systems for inhalation therapy of lung cancer.
Anabousi S; Bakowsky U; Schneider M; Huwer H; Lehr CM; Ehrhardt C
Eur J Pharm Sci; 2006 Dec; 29(5):367-74. PubMed ID: 16952451
[TBL] [Abstract][Full Text] [Related]
7. A novel transferrin receptor-targeted hybrid peptide disintegrates cancer cell membrane to induce rapid killing of cancer cells.
Kawamoto M; Horibe T; Kohno M; Kawakami K
BMC Cancer; 2011 Aug; 11():359. PubMed ID: 21849092
[TBL] [Abstract][Full Text] [Related]
8. New Transferrin Receptor-Targeted Peptide-Doxorubicin Conjugates: Synthesis and In Vitro Antitumor Activity.
Yu J; Mao X; Yang X; Zhao G; Li S
Molecules; 2024 Apr; 29(8):. PubMed ID: 38675578
[TBL] [Abstract][Full Text] [Related]
9. In vitro and initial in vivo evaluation of (68)Ga-labeled transferrin receptor (TfR) binding peptides as potential carriers for enhanced drug transport into TfR expressing cells.
Wängler C; Nada D; Höfner G; Maschauer S; Wängler B; Schneider S; Schirrmacher E; Wanner KT; Schirrmacher R; Prante O
Mol Imaging Biol; 2011 Apr; 13(2):332-41. PubMed ID: 20473573
[TBL] [Abstract][Full Text] [Related]
10. Enhancing Glioblastoma-Specific Penetration by Functionalization of Nanoparticles with an Iron-Mimic Peptide Targeting Transferrin/Transferrin Receptor Complex.
Kang T; Jiang M; Jiang D; Feng X; Yao J; Song Q; Chen H; Gao X; Chen J
Mol Pharm; 2015 Aug; 12(8):2947-61. PubMed ID: 26149889
[TBL] [Abstract][Full Text] [Related]
11. Expression of curcin-transferrin receptor binding peptide fusion protein and its anti-tumor activity.
Zheng Q; Xiong YL; Su ZJ; Zhang QH; Dai XY; Li LY; Xiao X; Huang YD
Protein Expr Purif; 2013 Jun; 89(2):181-8. PubMed ID: 23545225
[TBL] [Abstract][Full Text] [Related]
12. Glioma growth inhibition in vitro and in vivo by single chain variable fragments of the transferrin receptor conjugated to survivin small interfering RNA.
Wang F; Bai HR; Wang J; Bai YZ; Dou CW
J Int Med Res; 2011; 39(5):1701-12. PubMed ID: 22117970
[TBL] [Abstract][Full Text] [Related]
13. Anti-cancer activity of an acid-labile N-alkylisatin conjugate targeting the transferrin receptor.
Indira Chandran V; Matesic L; Locke JM; Skropeta D; Ranson M; Vine KL
Cancer Lett; 2012 Mar; 316(2):151-6. PubMed ID: 22115965
[TBL] [Abstract][Full Text] [Related]
14. Enhanced antitumor effect of anti-tissue factor antibody-conjugated epirubicin-incorporating micelles in xenograft models.
Yamamoto Y; Hyodo I; Koga Y; Tsumura R; Sato R; Obonai T; Fuchigami H; Furuya F; Yasunaga M; Harada M; Kato Y; Ohtsu A; Matsumura Y
Cancer Sci; 2015 May; 106(5):627-34. PubMed ID: 25711681
[TBL] [Abstract][Full Text] [Related]
15. Peptide-conjugated PAMAM for targeted doxorubicin delivery to transferrin receptor overexpressed tumors.
Han L; Huang R; Liu S; Huang S; Jiang C
Mol Pharm; 2010 Dec; 7(6):2156-65. PubMed ID: 20857964
[TBL] [Abstract][Full Text] [Related]
16. The molecular mechanism for receptor-stimulated iron release from the plasma iron transport protein transferrin.
Giannetti AM; Halbrooks PJ; Mason AB; Vogt TM; Enns CA; Björkman PJ
Structure; 2005 Nov; 13(11):1613-23. PubMed ID: 16271884
[TBL] [Abstract][Full Text] [Related]
17. Development of human single-chain antibodies to the transferrin receptor that effectively antagonize the growth of leukemias and lymphomas.
Crépin R; Goenaga AL; Jullienne B; Bougherara H; Legay C; Benihoud K; Marks JD; Poul MA
Cancer Res; 2010 Jul; 70(13):5497-506. PubMed ID: 20530676
[TBL] [Abstract][Full Text] [Related]
18. Mechanism for multiple ligand recognition by the human transferrin receptor.
Giannetti AM; Snow PM; Zak O; Björkman PJ
PLoS Biol; 2003 Dec; 1(3):E51. PubMed ID: 14691533
[TBL] [Abstract][Full Text] [Related]
19. Combination of sequence-defined oligoaminoamides with transferrin-polycation conjugates for receptor-targeted gene delivery.
Zhang W; Rödl W; He D; Döblinger M; Lächelt U; Wagner E
J Gene Med; 2015; 17(8-9):161-72. PubMed ID: 26227403
[TBL] [Abstract][Full Text] [Related]
20. Transferrin receptor-targeted theranostic gold nanoparticles for photosensitizer delivery in brain tumors.
Dixit S; Novak T; Miller K; Zhu Y; Kenney ME; Broome AM
Nanoscale; 2015 Feb; 7(5):1782-90. PubMed ID: 25519743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
